Rhythm Biosciences (FRA:0RY) Total Assets: €1.76 Mil (As of Dec. 2025)


FRA:0RY Rhythm Biosciences Ltd FRA:0RY
31 GF Score
Price €0.06
! 5 Warning Signs
View Full Analysis

What is Rhythm Biosciences Total Assets?

Rhythm Biosciences FRA:0RY +10.58% 31 Total Assets is €1.76 Mil as of Dec. 2025. GuruFocus rates FRA:0RY with a GF Score™ of 31/100. The stock has 5 warning signs investors should review.

Rhythm Biosciences's Total Assets for the quarter that ended in Dec. 2025 was €1.76 Mil.

During the past 12 months, Rhythm Biosciences's average Total Assets Growth Rate was -12.20% per year. During the past 3 years, the average Total Assets Growth Rate was 17.00% per year. During the past 5 years, the average Total Assets Growth Rate was 11.80% per year.

During the past 8 years, Rhythm Biosciences's highest 3-Year average Total Assets Growth Rate was 63.80%. The lowest was -16.70%. And the median was 8.50%.

Total Assets is connected with ROA %. Rhythm Biosciences's annualized ROA % for the quarter that ended in Dec. 2025 was -152.59%. Total Assets is also linked to Revenue through Asset Turnover. Rhythm Biosciences's Asset Turnover for the quarter that ended in Dec. 2025 was 0.02.

Rhythm Biosciences  (FRA:0RY) Total Assets Explanation

Total Assets is connected with ROA %.

Rhythm Biosciences's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-2.562/( (1.599+1.759)/ 2 )
=-2.562/1.679
=-152.59 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Rhythm Biosciences's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0.026/( (1.599+1.759)/ 2 )
=0.026/1.679
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Rhythm Biosciences Total Assets Related Terms

Rhythm Biosciences Total Assets Historical Data

* Premium members only.

The historical data trend for Rhythm Biosciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhythm Biosciences Total Assets Chart

Rhythm Biosciences Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Assets
Get a 7-Day Free Trial 1.95 5.61 4.77 0.94 1.60

Rhythm Biosciences Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.19 0.94 3.59 1.60 1.76
FRA:0RY
31GF Score
Rhythm Biosciences Ltd FRA:0RY
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rhythm Biosciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Rhythm Biosciences's Total Assets for the fiscal year that ended in Jun. 2025 is calculated as

Total Assets=Total Equity (A: Jun. 2025 )+Total Liabilities (A: Jun. 2025 )
=0.373+1.226
=1.60

Rhythm Biosciences's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=1.216+0.542
=1.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of €1.76 Mil mean?
Rhythm Biosciences (FRA:0RY) has a Total Assets of €1.76 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Rhythm Biosciences and its competitors.
Is Rhythm Biosciences' Total Assets too high?
Rhythm Biosciences' current Total Assets is €1.76 Mil. Overall, Rhythm Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Rhythm Biosciences' Total Assets compare to TMO and DHR?
Rhythm Biosciences' Total Assets of €1.76 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Diagnostics & Research company?
A good Total Assets depends on the Medical Diagnostics & Research industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Rhythm Biosciences and its competitors. Rhythm Biosciences's current Total Assets is €1.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhythm Biosciences stock overvalued right now?
Rhythm Biosciences (FRA:0RY) has a current Total Assets of €1.76 Mil. The current Total Assets is €1.76 Mil. Rhythm Biosciences' overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Rhythm Biosciences (FRA:0RY), the current Total Assets is €1.76 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rhythm Biosciences Business Description

Other Exchanges RHY:Australia
Address 30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. The product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. The company operates predominantly in one business and geographical segment which is the research and development of biosciences in Australia.
31GF Score

Get the complete analysis for FRA:0RY

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.06
Price